Carboxyl group-modified α-lactalbumin induces TNF-α-mediated apoptosis in leukemia and breast cancer cells through the NOX4/p38 MAPK/PP2A axis

Int J Biol Macromol. 2021 Sep 30:187:513-527. doi: 10.1016/j.ijbiomac.2021.07.133. Epub 2021 Jul 24.

Abstract

To clarify the mechanism of semicarbazide-modified α-lactalbumin (SEM-LA)-mediated cytotoxicity, we investigated its effect on human U937 leukemia cells and MCF-7 breast cancer cells in the current study. SEM-LA induced apoptosis in U937 cells, which showed increased NOX4 expression, procaspase-8 degradation, and t-Bid production. FADD depletion inhibited SEM-LA-elicited caspase-8 activation, t-Bid production, and cell death, indicating that SEM-LA activated death receptor-mediated apoptosis in U937 cells. SEM-LA stimulated Ca2+-mediated Akt activation, which in turn increased Sp1- and p300-mediated NOX4 transcription. The upregulation of NOX4 expression promoted ROS-mediated p38 MAPK phosphorylation, leading to protein phosphatase 2A (PP2A)-regulated tristetraprolin (TTP) degradation. Remarkably, TTP downregulation increased the stability of TNF-α mRNA, resulting in the upregulation of TNF-α protein expression. Abolishment of Ca2+-NOX4-ROS axis-mediated p38 MAPK activation attenuated SEM-LA-induced TNF-α upregulation and protected U937 cells from SEM-LA-mediated cytotoxicity. The restoration of TTP expression alleviated the effect of TNF-α upregulation and cell death induced by SEM-LA. Altogether, the data in this study demonstrate that SEM-LA activates TNF-α-mediated apoptosis in U937 cells through the NOX4/p38 MAPK/PP2A axis. We think that a similar pathway can also explain the death of MCF-7 human breast cancer cells after SEM-LA treatment.

Keywords: NOX4; Protein phosphatase 2A; TNF-α; Tristetraprolin; p38 MAPK; α-Lactalbumin.

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects*
  • Apoptosis Regulatory Proteins / metabolism
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / enzymology
  • Breast Neoplasms / genetics
  • Breast Neoplasms / pathology
  • Calcium Signaling / drug effects
  • E1A-Associated p300 Protein / genetics
  • E1A-Associated p300 Protein / metabolism
  • Female
  • Humans
  • Lactalbumin / pharmacology*
  • Leukemia / drug therapy*
  • Leukemia / enzymology
  • Leukemia / genetics
  • Leukemia / pathology
  • MCF-7 Cells
  • NADPH Oxidase 4 / genetics
  • NADPH Oxidase 4 / metabolism*
  • Protein Phosphatase 2 / genetics
  • Protein Phosphatase 2 / metabolism*
  • Proteolysis
  • Reactive Oxygen Species / metabolism
  • Semicarbazides / pharmacology*
  • Sp1 Transcription Factor / genetics
  • Sp1 Transcription Factor / metabolism
  • Tristetraprolin / metabolism
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / metabolism*
  • U937 Cells
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Antineoplastic Agents
  • Apoptosis Regulatory Proteins
  • Reactive Oxygen Species
  • Semicarbazides
  • Sp1 Transcription Factor
  • TNF protein, human
  • Tristetraprolin
  • Tumor Necrosis Factor-alpha
  • ZFP36 protein, human
  • carbamylhydrazine
  • Lactalbumin
  • NADPH Oxidase 4
  • NOX4 protein, human
  • E1A-Associated p300 Protein
  • EP300 protein, human
  • p38 Mitogen-Activated Protein Kinases
  • Protein Phosphatase 2